Biomx Inc Stock Ownership - Who owns Biomx?

Insider buying vs selling

Have Biomx Inc insiders been buying or selling?
Assaf OronChief Business Officer2023-05-223,192$0.27
Assaf OronChief Business Officer2023-05-196,521$0.28
Assaf OronChief Business Officer2023-05-181,201$0.27
Orbimed Israel Biofund GP Limited Partnership10% Owner2023-02-27348,000$0.25
Chidozie UgwumbaInsider2022-11-041,501$0.38
Chidozie UgwumbaInsider2022-11-032,000$0.37
Chidozie UgwumbaInsider2022-11-022,416$0.36
Chidozie UgwumbaInsider2022-11-011,300$0.36
Chidozie UgwumbaInsider2022-10-313,300$0.37
Chidozie UgwumbaInsider2022-10-281,526$0.36

1 of 7

PHGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHGE insiders and whales buy or sell their stock.

PHGE Shareholders

What type of owners hold Biomx Inc stock?
Erez Chimovits10.06%4,626,978$1.39MInsider
Orbimed Israel Biofund GP Limited Partnership6.88%3,161,489$948.45kInsider
Orbimed Advisors LLC6.88%3,161,489$948.45kInstitution
Chidozie Ugwumba6.52%2,997,025$899.11kInsider
Takeda Pharmaceutical Co Ltd5.37%2,470,935$741.28kInsider
Johnson Johnson4.64%2,133,402$640.02kInstitution
Jonas Grossman4.52%2,080,217$624.07kInsider
Mmcap International Inc Spc1.32%608,162$182.45kInstitution
Gbolahan Amusa0.57%262,871$78.86kInsider
Kerry Propper0.57%260,771$78.23kInsider

1 of 3

PHGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHGE13.82%34.65%Net SellingNet Buying
INFI21.48%22.42%Net Buying
ACGN0.18%99.82%Net BuyingNet Selling
CNTX8.06%7.22%Net Buying

Biomx Stock Ownership FAQ

Who owns Biomx?

Biomx (NYSEMKT: PHGE) is owned by 13.82% institutional shareholders, 34.65% Biomx insiders, and 51.53% retail investors. Erez Chimovits is the largest individual Biomx shareholder, owning 4.63M shares representing 10.06% of the company. Erez Chimovits's Biomx shares are currently valued at $1.39M.

If you're new to stock investing, here's how to buy Biomx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.